{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:05Z","timestamp":1787020925175,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY023427"],"award-info":[{"award-number":["EY023427"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Hamilton Eye Institute"],"award-info":[{"award-number":["Hamilton Eye Institute"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-1059-y","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T08:04:03Z","timestamp":1542787443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse"],"prefix":"10.1186","volume":"9","author":[{"given":"Sally L.","family":"Elshaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickey","family":"Pentecost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji","family":"Lenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Periasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Abhiram","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Alli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordy","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-8286","authenticated-orcid":false,"given":"Rajashekhar","family":"Gangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"3","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ajo.2006.11.058","volume":"143","author":"R Klein","year":"2007","unstructured":"Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL, Kuppermann BD, Langer RD, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women\u2019s Health Initiative Sight Exam ancillary study. Am J Ophthalmol. 2007;143(3):473\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","volume":"54","author":"R Klein","year":"2013","unstructured":"Klein R, Klein BE. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci. 2013;54(14):ORSF5\u2013ORSF13.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2337\/diacare.21.1.143","volume":"21","author":"LP Aiello","year":"1998","unstructured":"Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 1998;21(1):143\u201356.","journal-title":"Diabetes Care"},{"issue":"12","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4103\/0019-5359.48562","volume":"62","author":"CA Shah","year":"2008","unstructured":"Shah CA. Diabetic retinopathy: a comprehensive review. Indian J Med Sci. 2008;62(12):500\u201319.","journal-title":"Indian J Med Sci"},{"issue":"4","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552\u201363.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527\u201332.","journal-title":"Arch Ophthalmol"},{"key":"1059_CR8","doi-asserted-by":"crossref","unstructured":"Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796\u2013806.","DOI":"10.1001\/archopht.1985.01050120030015"},{"key":"1059_CR9","doi-asserted-by":"crossref","unstructured":"Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1976;81(4):383\u201396.","DOI":"10.1016\/0002-9394(76)90292-0"},{"issue":"5","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/IAE.0000000000001280","volume":"37","author":"TL Jackson","year":"2017","unstructured":"Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P. Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina. 2017;37(5):886\u201395.","journal-title":"Retina"},{"key":"1059_CR11","doi-asserted-by":"crossref","unstructured":"Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1. Ophthalmology. 1985;92(4):492\u2013502.","DOI":"10.1016\/S0161-6420(85)34002-2"},{"issue":"1","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/157339909787314121","volume":"5","author":"JF Arevalo","year":"2009","unstructured":"Arevalo JF, Garcia-Amaris RA. Intravitreal bevacizumab for diabetic retinopathy. Curr Diabetes Rev. 2009;5(1):39\u201346.","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/eye.2008.40","volume":"23","author":"A Ozkiris","year":"2009","unstructured":"Ozkiris A. Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema. Eye (Lond). 2009;23(3):616\u201320.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/IAE.0b013e318186c64e","volume":"29","author":"R Velez-Montoya","year":"2009","unstructured":"Velez-Montoya R, Fromow-Guerra J, Burgos O, Landers MB 3rd, Morales-Caton V, Quiroz-Mercado H. The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study. Retina. 2009;29(1):20\u20136.","journal-title":"Retina"},{"issue":"9","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","volume":"26","author":"C Haritoglou","year":"2006","unstructured":"Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina. 2006;26(9):999\u20131005.","journal-title":"Retina"},{"issue":"6","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","volume":"117","author":"M Michaelides","year":"2010","unstructured":"Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology. 2010;117(6):1078\u20131086.e2.","journal-title":"Ophthalmology"},{"issue":"9","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/17425247.2016.1198771","volume":"13","author":"MW Stewart","year":"2016","unstructured":"Stewart MW, Flynn HW Jr, Schwartz SG, Scott IU. Extended duration strategies for the pharmacologic treatment of diabetic retinopathy: current status and future prospects. Expert Opin Drug Deliv. 2016;13(9):1277\u201387.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/IAE.0b013e3181c70168","volume":"30","author":"T Hattori","year":"2010","unstructured":"Hattori T, Shimada H, Nakashizuka H, Mizutani Y, Mori R, Yuzawa M. Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy. Retina. 2010;30(5):761\u20134.","journal-title":"Retina"},{"issue":"4","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ajo.2006.04.058","volume":"142","author":"JO Mason 3rd","year":"2006","unstructured":"Mason JO 3rd, Nixon PA, White MF. Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142(4):685\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"9735","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000459691","volume":"60","author":"R Lattanzio","year":"2017","unstructured":"Lattanzio R, Cicinelli MV, Bandello F. Intravitreal steroids in diabetic macular edema. Dev Ophthalmol. 2017;60:78\u201390.","journal-title":"Dev Ophthalmol"},{"issue":"4","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1242\/dmm.009597","volume":"5","author":"R Robinson","year":"2012","unstructured":"Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech. 2012;5(4):444\u201356.","journal-title":"Dis Model Mech"},{"issue":"3","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s40610-017-0069-3","volume":"3","author":"S Bhattacharya","year":"2017","unstructured":"Bhattacharya S, Gangaraju R, Chaum E. Recent advances in retinal stem cell therapy. Curr Mol Biol Rep. 2017;3(3):172\u201382.","journal-title":"Curr Mol Biol Rep"},{"issue":"1","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"e84671","DOI":"10.1371\/journal.pone.0084671","volume":"9","author":"G Rajashekhar","year":"2014","unstructured":"Rajashekhar G, Ramadan A, Abburi C, Callaghan B, Traktuev DO, Evans-Molina C, Maturi R, Harris A, Kern TS, March KL. Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS One. 2014;9(1):e84671.","journal-title":"PLoS One"},{"issue":"5","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"e65691","DOI":"10.1371\/journal.pone.0065691","volume":"8","author":"TA Mendel","year":"2013","unstructured":"Mendel TA, Clabough EB, Kao DS, Demidova-Rice TN, Durham JT, Zotter BC, Seaman SA, Cronk SM, Rakoczy EP, Katz AJ, Herman IM, Peirce SM, Yates PA. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One. 2013;8(5):e65691.","journal-title":"PLoS One"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-016-0299-y","volume":"7","author":"M Ezquer","year":"2016","unstructured":"Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther. 2016;7:42.","journal-title":"Stem Cell Res Ther"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2014.00059","volume":"5","author":"G Rajashekhar","year":"2014","unstructured":"Rajashekhar G. Mesenchymal stem cells: new players in retinopathy therapy. Front Endocrinol (Lausanne). 2014;5:59.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000448180","volume":"43","author":"L Frese","year":"2016","unstructured":"Frese L, Dijkman PE, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43(4):268\u201374.","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/CIRCRESAHA.107.159475","volume":"102","author":"DO Traktuev","year":"2008","unstructured":"Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res. 2008;102(1):77\u201385.","journal-title":"Circ Res"},{"issue":"2","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/stem.1285","volume":"31","author":"CW Chen","year":"2013","unstructured":"Chen CW, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, Corselli M, Crisan M, Saparov A, Tobita K, Peault B, Huard J. Human pericytes for ischemic heart repair. Stem Cells. 2013;31(2):305\u201316.","journal-title":"Stem Cells"},{"issue":"11","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"e48648","DOI":"10.1371\/journal.pone.0048648","volume":"7","author":"A Bouacida","year":"2012","unstructured":"Bouacida A, Rosset P, Trichet V, Guilloton F, Espagnolle N, Cordonier T, Heymann D, Layrolle P, Sensebe L, Deschaseaux F. Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One. 2012;7(11):e48648.","journal-title":"PLoS One"},{"issue":"9","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3928\/23258160-20170829-16","volume":"48","author":"SS Saraf","year":"2017","unstructured":"Saraf SS, Cunningham MA, Kuriyan AE, Read SP, Rosenfeld PJ, Flynn HW Jr, Albini TA. Bilateral retinal detachments after intravitreal injection of adipose-derived \u2018stem cells\u2019 in a patient with exudative macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2017;48(9):772\u20135.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"11","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","volume":"376","author":"AE Kuriyan","year":"2017","unstructured":"Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE 2nd, Parrott MB, Rosenfeld PJ, Flynn HW Jr, Goldberg JL. Vision loss after intravitreal injection of autologous \u201cstem cells\u201d for AMD. N Engl J Med. 2017;376(11):1047\u201353.","journal-title":"N Engl J Med"},{"key":"1059_CR34","first-page":"106","volume":"10","author":"R Zhang","year":"2013","unstructured":"Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P, Chen FF, Jiang XD. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation. 2013;10:106.","journal-title":"J Neuroinflammation"},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1742-2094-11-135","volume":"11","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zhang R, Yan K, Chen F, Huang W, Lv B, Sun C, Xu L, Li F, Jiang X. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J Neuroinflammation. 2014;11:135.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/stem.1851","volume":"33","author":"J Xie","year":"2015","unstructured":"Xie J, Broxmeyer HE, Feng D, Schweitzer KS, Yi R, Cook TG, Chitteti BR, Barwinska D, Traktuev DO, Van Demark MJ, Justice MJ, Ou X, Srour EF, Prockop DJ, Petrache I, March KL. Human adipose-derived stem cells ameliorate cigarette smoke-induced murine myelosuppression via secretion of TSG-6. Stem Cells. 2015;33(2):468\u201378.","journal-title":"Stem Cells"},{"issue":"2","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-kappaB signaling in resident macrophages. Blood. 2011;118(2):330\u20138.","journal-title":"Blood"},{"issue":"1","key":"1059_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/stem.2730","volume":"36","author":"MT Harting","year":"2018","unstructured":"Harting MT, Srivastava AK, Zhaorigetu S, Bair H, Prabhakara KS, Toledano Furman NE, Vykoukal JV, Ruppert KA, Cox CS Jr, Olson SD. Inflammation-stimulated mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation. Stem Cells. 2018;36(1):79\u201390.","journal-title":"Stem Cells"},{"issue":"6","key":"1059_CR39","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46(6):2210\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1059_CR40","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.2337\/db14-1030","volume":"64","author":"JM Cahoon","year":"2015","unstructured":"Cahoon JM, Rai RR, Carroll LS, Uehara H, Zhang X, O'Neil CL, Medina RJ, Das SK, Muddana SK, Olson PR, Nielson S, Walker K, Flood MM, Messenger WB, Archer BJ, Barabas P, Krizaj D, Gibson CC, Li DY, Koh GY, Gao G, Stitt AW, Ambati BK. Intravitreal AAV2.COMP-Ang1 prevents neurovascular degeneration in a murine model of diabetic retinopathy. Diabetes. 2015;64(12):4247\u201359.","journal-title":"Diabetes"},{"key":"1059_CR41","doi-asserted-by":"crossref","unstructured":"Periasamy R, Elshaer SL, Gangaraju R. CD140b (PDGFR\u03b2) signaling in adipose-derived stem cells mediates angiogenic behavior of retinal endothelial cells. Regen Eng Transl Med. 2018; In Press ( https:\/\/rdcu.be\/2caQ ).","DOI":"10.1007\/s40883-018-0068-9"},{"key":"1059_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exer.2014.03.004","volume":"122","author":"G Rajashekhar","year":"2014","unstructured":"Rajashekhar G, Shivanna M, Kompella UB, Wang Y, Srinivas SP. Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-alpha. Exp Eye Res. 2014;122:77\u201385.","journal-title":"Exp Eye Res"},{"issue":"12","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1167\/iovs.04-0541","volume":"45","author":"GT Prusky","year":"2004","unstructured":"Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004;45(12):4611\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1059_CR44","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1002\/jcb.27072","volume":"119","author":"Raji Lenin","year":"2018","unstructured":"Lenin R, Nagy PG, Alli S, Rao VR, Clauss MA, Kompella UB, Gangaraju R. Critical role of endoplasmic reticulum stress in chronic endothelial activation-induced visual deficits in tie2-tumor necrosis factor mice. J Cell Biochem. 2018;119(10):8460-71.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"4","key":"1059_CR45","doi-asserted-by":"publisher","first-page":"e5149","DOI":"10.1371\/journal.pone.0005149","volume":"4","author":"TE Walshe","year":"2009","unstructured":"Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One. 2009;4(4):e5149.","journal-title":"PLoS One"},{"issue":"6","key":"1059_CR46","doi-asserted-by":"publisher","first-page":"e99036","DOI":"10.1371\/journal.pone.0099036","volume":"9","author":"TW Corson","year":"2014","unstructured":"Corson TW, Samuels BC, Wenzel AA, Geary AJ, Riley AA, McCarthy BP, Hanenberg H, Bailey BJ, Rogers PI, Pollok KE, Rajashekhar G, Territo PR. Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development. PLoS One. 2014;9(6):e99036.","journal-title":"PLoS One"},{"issue":"10","key":"1059_CR47","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1167\/iovs.09-5147","volume":"51","author":"Q Li","year":"2010","unstructured":"Li Q, Verma A, Han PY, Nakagawa T, Johnson RJ, Grant MB, Campbell-Thompson M, Jarajapu YP, Lei B, Hauswirth WW. Diabetic eNOS-knockout mice develop accelerated retinopathy. Invest Ophthalmol Vis Sci. 2010;51(10):5240\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"e21164","DOI":"10.1371\/journal.pone.0021164","volume":"6","author":"J Cai","year":"2011","unstructured":"Cai J, Wu L, Qi X, Li Calzi S, Caballero S, Shaw L, Ruan Q, Grant MB, Boulton ME. PEDF regulates vascular permeability by a gamma-secretase-mediated pathway. PLoS One. 2011;6(6):e21164.","journal-title":"PLoS One"},{"issue":"1","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lfs.2014.02.023","volume":"102","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhang ZM. Oxygen-induced retinopathy in mice with retinal photoreceptor cell degeneration. Life Sci. 2014;102(1):28\u201335.","journal-title":"Life Sci"},{"issue":"5","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jsgi.2005.02.010","volume":"12","author":"G Rajashekhar","year":"2005","unstructured":"Rajashekhar G, Loganath A, Roy AC, Chong SS, Wong YC. Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J Soc Gynecol Investig. 2005;12(5):310\u20139.","journal-title":"J Soc Gynecol Investig"},{"key":"1059_CR51","first-page":"796","volume":"19","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Jiang Y, Toutounchian JJ, Soderland C, Yates CR, Steinle JJ. Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions. Mol Vis. 2013;19:796\u2013803.","journal-title":"Mol Vis"},{"issue":"7","key":"1059_CR52","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.2337\/db07-1520","volume":"57","author":"JV Busik","year":"2008","unstructured":"Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57(7):1952\u201365.","journal-title":"Diabetes"},{"issue":"1","key":"1059_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mcn.2012.04.003","volume":"50","author":"GN Costa","year":"2012","unstructured":"Costa GN, Vindeirinho J, Cavadas C, Ambrosio AF, Santos PF. Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose. Mol Cell Neurosci. 2012;50(1):113\u201323.","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"1059_CR54","doi-asserted-by":"publisher","first-page":"e97970","DOI":"10.1371\/journal.pone.0097970","volume":"9","author":"JR Hombrebueno","year":"2014","unstructured":"Hombrebueno JR, Chen M, Penalva RG, Xu H. Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse. PLoS One. 2014;9(5):e97970.","journal-title":"PLoS One"},{"issue":"6","key":"1059_CR55","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/ceo.12084","volume":"41","author":"S McLenachan","year":"2013","unstructured":"McLenachan S, Chen X, McMenamin PG, Rakoczy EP. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. Clin Exp Ophthalmol. 2013;41(6):582\u201392.","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"1059_CR56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.exer.2005.07.018","volume":"82","author":"I Iandiev","year":"2006","unstructured":"Iandiev I, Biedermann B, Bringmann A, Reichel MB, Reichenbach A, Pannicke T. Atypical gliosis in Muller cells of the slowly degenerating RDS mutant mouse retina. Exp Eye Res. 2006;82(3):449\u201357.","journal-title":"Exp Eye Res"},{"issue":"4","key":"1059_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12177-009-9045-3","volume":"2","author":"WM Freeman","year":"2009","unstructured":"Freeman WM, Bixler GV, Brucklacher RM, Walsh E, Kimball SR, Jefferson LS, Bronson SK. Transcriptomic comparison of the retina in two mouse models of diabetes. J Ocul Biol Dis Inform. 2009;2(4):202\u201313.","journal-title":"J Ocul Biol Dis Inform"},{"issue":"6","key":"1059_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641\u20138.","journal-title":"Cytotherapy"},{"issue":"6","key":"1059_CR59","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10059-013-0112-z","volume":"35","author":"YJ Ryu","year":"2013","unstructured":"Ryu YJ, Cho TJ, Lee DS, Choi JY, Cho J. Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells. Mol Cell. 2013;35(6):557\u201364.","journal-title":"Mol Cell"},{"issue":"10","key":"1059_CR60","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3858\/emm.2011.43.10.069","volume":"43","author":"SJ Baek","year":"2011","unstructured":"Baek SJ, Kang SK, Ra JC. In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med. 2011;43(10):596\u2013603.","journal-title":"Exp Mol Med"},{"issue":"9","key":"1059_CR61","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ijo.2010.269","volume":"35","author":"M Maumus","year":"2011","unstructured":"Maumus M, Peyrafitte JA, D'Angelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, Sengenes C, Bourin P. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes. 2011;35(9):1141\u201353.","journal-title":"Int J Obes"},{"issue":"12","key":"1059_CR62","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/j.1582-4934.2012.01617.x","volume":"16","author":"M Crisan","year":"2012","unstructured":"Crisan M, Corselli M, Chen WC, Peault B. Perivascular cells for regenerative medicine. J Cell Mol Med. 2012;16(12):2851\u201360.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1059_CR63","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1167\/iovs.09-4509","volume":"51","author":"TV Johnson","year":"2010","unstructured":"Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, Martin KR. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51(4):2051\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1059_CR64","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3390\/ijms19072016","volume":"19","author":"Kumar Jha","year":"2018","unstructured":"Jha KA, Pentecost M, Lenin R, Klaic L, Elshaer SL, Gentry J, Russell JM, Beland A, Reiner A, Jotterand V, Sohl N, Gangaraju R. Concentrated conditioned media from adipose tissue derived mesenchymal stem cells mitigates visual deficits and retinal inflammation following mild traumatic brain injury. Int J Mol Sci. 2018;19(7):E2016.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"1059_CR65","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12015-010-9178-6","volume":"6","author":"K Kemp","year":"2010","unstructured":"Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev. 2010;6(4):548\u201359.","journal-title":"Stem Cell Rev"},{"key":"1059_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.matbio.2016.01.010","volume":"51","author":"DJ Prockop","year":"2016","unstructured":"Prockop DJ. Inflammation, fibrosis, and modulation of the process by mesenchymal stem\/stromal cells. Matrix Biol. 2016;51:7\u201313.","journal-title":"Matrix Biol"},{"key":"1059_CR67","doi-asserted-by":"publisher","first-page":"11872","DOI":"10.1038\/srep11872","volume":"5","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Lee HJ, Yun JH, Ko JH, Choi DY, Oh JY. Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment. Sci Rep. 2015;5:11872.","journal-title":"Sci Rep"},{"key":"1059_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1742-2094-9-59","volume":"9","author":"J Tuo","year":"2012","unstructured":"Tuo J, Cao X, Shen D, Wang Y, Zhang J, Oh JY, Prockop DJ, Chan CC. Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J Neuroinflammation. 2012;9:59.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1059_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/ijms19010110","volume":"19","author":"C Altmann","year":"2018","unstructured":"Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 2018;19(1):110.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1059_CR70","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","volume":"22","author":"R Chinnadurai","year":"2018","unstructured":"Chinnadurai R, Rajan D, Qayed M, Arafat D, Garcia M, Liu Y, Kugathasan S, Anderson LJ, Gibson G, Galipeau J. Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach. Cell Rep. 2018;22(9):2504\u201317.","journal-title":"Cell Rep"},{"key":"1059_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","volume":"28","author":"DS Kim","year":"2018","unstructured":"Kim DS, Jang IK, Lee MW, Ko YJ, Lee D-H, Lee JW, Sung KW, Koo HH, Yoo KH. Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-\u03b3. EBioMedicine. 2018;28:261\u201373.","journal-title":"EBioMedicine"},{"key":"1059_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fimmu.2018.00771","volume":"9","author":"K Hyv\u00e4rinen","year":"2018","unstructured":"Hyv\u00e4rinen K, Holopainen M, Skirdenko V, Ruhanen H, Lehenkari P, Korhonen M, K\u00e4kel\u00e4 R, Laitinen S, Kerkel\u00e4 E. Mesenchymal stromal cells and their extracellular vesicles enhance the anti-inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (IL)-23 and IL-22. Front Immunol. 2018;9:771.","journal-title":"Front Immunol"},{"issue":"7","key":"1059_CR73","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/stem.2369","volume":"34","author":"L Chiossone","year":"2016","unstructured":"Chiossone L, Conte R, Spaggiari GM, Serra M, Romei C, Bellora F, Becchetti F, Andaloro A, Moretta L, Bottino C. Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses. Stem Cells. 2016;34(7):1909\u201321.","journal-title":"Stem Cells"},{"issue":"9","key":"1059_CR74","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE, Roelofs H. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31(9):1980\u201391.","journal-title":"Stem Cells"},{"issue":"6","key":"1059_CR75","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1253\/circj.CJ-12-0930","volume":"77","author":"M Takahashi","year":"2013","unstructured":"Takahashi M, Suzuki E, Kumano S, Oba S, Sato T, Nishimatsu H, Kimura K, Nagano T, Hirata Y. Angiopoietin-1 mediates adipose tissue-derived stem cell-induced inhibition of neointimal formation in rat femoral artery. Circ J. 2013;77(6):1574\u201384.","journal-title":"Circ J"},{"issue":"13","key":"1059_CR76","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339.","journal-title":"N Engl J Med"},{"issue":"11","key":"1059_CR77","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00125-018-4713-0","volume":"61","author":"Ghazaleh Hajmousa","year":"2018","unstructured":"Hajmousa G, Przybyt E, Pfister F, Paredes-Juarez GA, Moganti K, Busch S, Kuipers J, Klaassen I, van Luyn MJA, Krenning G, Hammes HP, Harmsen MC. Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells. Diabetologia. 2018;61(11):2371-85.","journal-title":"Diabetologia"},{"issue":"12","key":"1059_CR78","doi-asserted-by":"publisher","first-page":"e82520","DOI":"10.1371\/journal.pone.0082520","volume":"8","author":"EA Heise","year":"2013","unstructured":"Heise EA, Marozas LM, Grafton SA, Green KM, Kirwin SJ, Fort PE. Strain-independent increases of crystallin proteins in the retina of type 1 diabetic rats. PLoS One. 2013;8(12):e82520.","journal-title":"PLoS One"},{"issue":"8","key":"1059_CR79","doi-asserted-by":"publisher","first-page":"e0160442","DOI":"10.1371\/journal.pone.0160442","volume":"11","author":"N Binz","year":"2016","unstructured":"Binz N, Rakoczy EP, Ali Rahman IS, Vagaja NN, Lai CM. Biomarkers for diabetic retinopathy - could endothelin 2 be part of the answer? PLoS One. 2016;11(8):e0160442.","journal-title":"PLoS One"},{"issue":"40","key":"1059_CR80","doi-asserted-by":"publisher","first-page":"E3830","DOI":"10.1073\/pnas.1315509110","volume":"110","author":"A Rattner","year":"2013","unstructured":"Rattner A, Yu H, Williams J, Smallwood PM, Nathans J. Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis. Proc Natl Acad Sci U S A. 2013;110(40):E3830\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1059_CR81","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/TA.0000000000001744","volume":"84","author":"DR Potter","year":"2018","unstructured":"Potter DR, Miyazawa BY, Gibb SL, Deng X, Togaratti PP, Croze RH, Srivastava AK, Trivedi A, Matthay M, Holcomb JB, Schreiber MA, Pati S. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma. J Trauma Acute Care Surg. 2018;84(2):245\u201356.","journal-title":"J Trauma Acute Care Surg"},{"key":"1059_CR82","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-015-0257-0","volume":"6","author":"Y Yang","year":"2015","unstructured":"Yang Y, Chen QH, Liu AR, Xu XP, Han JB, Qiu HB. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway. Stem Cell Res Ther. 2015;6:250.","journal-title":"Stem Cell Res Ther"},{"key":"1059_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12967-015-0422-3","volume":"13","author":"H Lu","year":"2015","unstructured":"Lu H, Poirier C, Cook T, Traktuev DO, Merfeld-Clauss S, Lease B, Petrache I, March KL, Bogatcheva NV. Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis. J Transl Med. 2015;13:67.","journal-title":"J Transl Med"},{"issue":"2","key":"1059_CR84","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1167\/iovs.12-10927","volume":"54","author":"MH Aung","year":"2013","unstructured":"Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT. Early visual deficits in streptozotocin-induced diabetic long evans rats. Invest Ophthalmol Vis Sci. 2013;54(2):1370\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1059_CR85","doi-asserted-by":"publisher","first-page":"e0146438","DOI":"10.1371\/journal.pone.0146438","volume":"11","author":"P-T Yeh","year":"2016","unstructured":"Yeh P-T, Huang H-W, Yang C-M, Yang W-S, Yang C-H. Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in Streptozotocin-induced diabetic rats. PLoS One. 2016;11(1):e0146438.","journal-title":"PLoS One"},{"issue":"5","key":"1059_CR86","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5966\/sctm.2014-0108","volume":"4","author":"SM Cronk","year":"2015","unstructured":"Cronk SM, Kelly-Goss MR, Ray HC, Mendel TA, Hoehn KL, Bruce AC, Dey BK, Guendel AM, Tavakol DN, Herman IM, Peirce SM, Yates PA. Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy. Stem Cells Transl Med. 2015;4(5):459\u201367.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"1059_CR87","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/sctm.16-0428","volume":"6","author":"B Mead","year":"2017","unstructured":"Mead B, Tomarev S. Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells Transl Med. 2017;6(4):1273\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"1059_CR88","doi-asserted-by":"publisher","first-page":"e109305","DOI":"10.1371\/journal.pone.0109305","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead B, Logan A, Berry M, Leadbeater W, Scheven BA. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS One. 2014;9(10):e109305.","journal-title":"PLoS One"},{"issue":"4","key":"1059_CR89","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jcyt.2015.12.002","volume":"18","author":"B Mead","year":"2016","unstructured":"Mead B, Hill LJ, Blanch RJ, Ward K, Logan A, Berry M, Leadbeater W, Scheven BA. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Cytotherapy. 2016;18(4):487\u201396.","journal-title":"Cytotherapy"},{"issue":"12","key":"1059_CR90","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25(12):2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1059_CR91","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/jnr.23063","volume":"90","author":"YJ Cho","year":"2012","unstructured":"Cho YJ, Song HS, Bhang S, Lee S, Kang BG, Lee JC, An J, Cha CI, Nam DH, Kim BS, Joo KM. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res. 2012;90(9):1794\u2013802.","journal-title":"J Neurosci Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1059-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T13:11:19Z","timestamp":1662469879000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1059-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Studies involving human adipose tissue were approved by UTHSC Institutional Review Board in accordance with relevant guidelines and regulations following the tenets of the Declaration of Helsinki. Institutional IRB approved the study as an exempt since the study involved de-identified cell lines from commercial sources. Animal studies were approved by the Institutional Animal Care and Use Committee, University of Tennessee Health Sciences Center (UTHSC), following the guidelines as per the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NS and RG are co-founders and hold equity in Cell Care Therapeutics Inc., whose interest is in the use of adipose-derived stromal cells in visual disorders. MP is an employee of Cell Care Therapeutics Inc. with equity. None of the other authors declare any financial conflicts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"322"}}